Close
American Drug Delivery & Formulation Summit
Xylem

DuPont Nutrition & Biosciences Unveils Cutting-Edge Solutions for Pharma Excipients at CPhI China 2019

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Enclomiphene Dosage and What to Expect in the First 90 Days

You have decided to try enclomiphene. Now what? For many...

Digital Twins in Pharmaceutical Manufacturing: Why Simulation Alone Is No Longer Enough

Pharmaceutical manufacturers have gotten very good at producing data....
- Advertisement -

DuPont Nutrition & Biosciences, a business unit of DuPont Specialty Products, is going to showcase a comprehensive portfolio of pharmaceutical solutions at CPhI China 2019 in Shanghai International Expo Center from June 18 to June 20.

The innovative range will address some of the most crucial drug formulation challenges currently faced by the industry.

Living up to this yearโ€™s event theme โ€œHealth by Innovationโ€, DuPont will share insights into formulation research, regulatory compliance, process improvement and process safety for biopharmaceutical products at a mini talk event attended by its existing and potential clients.

DuPont draws from the legacy of strong excipient suppliers Dow and FMC, to offer leading product brands and a one-stop technical and regulatory powerhouse that customers can rely on. The solutions not only address the tough challenges faced in pharmaceutical applications, but also enhance drug delivery performance and productivity.

Innovative Solutions for Growing Challenges
Powered by its rich expertise and international expertise, DuPont has positioned itself as a go-to supplier for excipients and active pharmaceutical ingredients, as well as supplement delivery solutions to meet evolving market needs. Its capabilities include a series of innovative excipients and in-depth processing technology, tailored for more effective and easily soluble drugs. DuPont solutions can be customized for better, varied tastes. DuPont also offers a range of soft and hard capsule solutions, all from renewable, plant-based resources.

At CPhI China 2019, DuPont will showcase features such as solubility enhancement, sustained release, as well as delayed or immediate release. The range includes:

  • METHOCELโ„ข DC2: It achieves superior process control with fewer production steps and less waste. With improved flow, faster and consistent tableting speeds, it greatly enhances overall production efficiency.
  • Avicelยฎ SMCC: This is an example of how DuPont has applied its extensive manufacturing and applications expertise to develop cutting-edge, co-processed excipients. With improved powder flow, content uniformity and tablet compactability, Avicelยฎ PH microcrystalline cellulose and its compounds keep pace with market movements and technological upgradation.

Another technology showcased by DuPont at this show is SeaGelยฎ, a tailored innovative solution which is highly aligned with the nutraceuticals market trends: clean, effective and attractive. This patented, environmentally-friendly technology enables sustainable in-house manufacturing of plant-based soft capsules. The SeaGelยฎ capsules have thermal and PH stabilizing properties and superior consumer appeal, providing an elegant and easily ingestible vegetarian alternative to gelatin.

Against the backdrop of growing need of pharmaceutical companies to streamline processes and improve efficiency, the company also highlights its continuous manufacturing with the binary mixture of excipient composite and API that are easier to set up, run, monitor, and clean than using the individual ingredients. The technology has a great potential to simplify and accelerate production.

โ€œThis year at the CPhI, we seek to raise awareness about our long and proven technical expertise to help businesses and benefit customers. Our rich portfolio of diverse solutions and offerings delivers a wide range of effective ingredients essential to our customersโ€™ success in the pharmaceutical industry. Our pioneering products reach far and wide โ€” delivering better results for all,โ€ said Rina Chokshi, Global Commercial Marketing Leader of Pharma Solutions at DuPont Nutrition & Biosciences.

Pauel Fokin, Global Commercial Director of Pharma Solutions at Nutrition & Biosciences added, โ€œThese days, pharmaceutical companies face increasing quality and regulatory requirements that hold back the development of new, pharma-specific excipients. This exhibition gives us the opportunity to directly connect the customers with our scientists, facilitating customized solutions and unique formulations for various process needs. In combination with other technical services and support, we aim to help the industry players to receive faster, easier approvals for their excipients.โ€

During the show, there is an array of real-world DuPont products and solutions on display. This gives people the opportunities to see first-hand what strengths and benefits these solutions will provide. Meanwhile, several mini talks will be held on the booth to give the audience a better and deep understanding of how innovative these solutions are. Visit DuPont booth in Hall 3 Booth No. 36.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Enclomiphene Dosage and What to Expect in the First 90 Days

You have decided to try enclomiphene. Now what? For many...

Digital Twins in Pharmaceutical Manufacturing: Why Simulation Alone Is No Longer Enough

Pharmaceutical manufacturers have gotten very good at producing data....

Novartis and Antares Therapeutics Form Strategic Partnership for Cancer Drug Development

Novartis has finalized a significant collaboration agreement with Antares...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป